Clinical study on cognitive impairment in Duchenne muscular dystrophy

Neuromuscul Disord. 2023 Jul;33(7):596-604. doi: 10.1016/j.nmd.2023.06.001. Epub 2023 Jun 17.

Abstract

Our study aimed to explore the intellectual function of patients with Duchenne muscular dystrophy (DMD) in China and examine the correlation of full-scale intelligence quotient (FSIQ) with age, mutation locations, mutation class, and dystrophin isoforms. We assessed 64 boys with DMD using The Wechsler Intelligence Scales for Children-Fourth Edition and compared intellectual function at enrollment and follow-up in the 15 patients who completed the follow-up. Our findings confirm that boys with DMD may exhibit cognitive impairment, with the Working Memory Index being the most impaired. There was no significant correlation between FSIQ and age; however, a positive correlation was noted between age and the Verbal Comprehension Index. FSIQ was not associated with mutation class, the number of affected mutated exons, or mutation locations. However, there was a significant difference in FSIQ between the groups with intact and deficient Dp140. Fifteen participants adhered to glucocorticoid therapy throughout the two-year follow-up period, and eleven of them showed an improvement in FSIQ compared to their initial scores, with improvement ranging from 2 to 20. In conclusion, patients with the cumulative loss of isoforms in the brain are at a higher risk of cognitive deficits and may require early cognitive interventions.

Keywords: Cognitive impairment; Duchenne muscular dystrophy; Dystrophin; Glucocorticoids.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain
  • Child
  • Cognition Disorders* / etiology
  • Cognitive Dysfunction* / etiology
  • Dystrophin / genetics
  • Humans
  • Male
  • Muscular Dystrophy, Duchenne* / genetics
  • Protein Isoforms

Substances

  • Dystrophin
  • Protein Isoforms